Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Your clinician can help design a personalized combination based on your goals
What are you trying to achieve
Some healthcare providers will prescribe Rybelsus off-label for weight loss for patients who meet eligibility
Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) Initial FDA Approval: 2016 Side Effect Update Date: November 1, 2024 Medication Description: Treats type 2 diabetes Updated GLP-1 Drugs Side Effects/Safety Information: Warns about the serious risk of pulmonary aspiration during general anesthesia or deep sedation
Warning: If you are pregnant or lactating, have any health condition or are taking any medication, consult your health professional before use
US$ 28.66
US$ 29.60
US$ 24.59
US$ 28.06
